Classification Brand-Generic Indication Mechanism of Contraindication Adverse Reaction Nursing Responsibilities

Name Action

Therapeutic Generic Name: Tramadol is Acting analgesic Contraindicated in CNS: dizziness, Assessment:
class: Tramadol indicated in that has opioid patients headache,  Assess BP and RR before
Analgesics moderate to severe agonist properties. hypersensitive to somnolence, vertigo, and periodically during
chronic pain and to It binds to μ-opiate drug or opioids. seizures, anxiety, administration.
Brand Name: postoperative pain. receptors in the asthenia, CNS  Assess onset, type,
Pharmacologic Ambidol CNS resulting in stimulation, location, and duration
class: inhibition of confusion, of pain.
Synthetic ascending pain coordination  Assess previous
centrally active pathways, thus disturbance, analgesic history.
analgesics altering the euphoria, malaise, Tramadol is not
perception of and nervousness, sleep recommended for
Dosage and response to pain. disorder, fever, patients dependent on
Frequency: Its inhibition of paresthenia, tremor, opioids.
50 mg/cap neuronal uptake of depression,  Tramadol exposes
300mg/50ml norepinephrine insomnia, agitation, patients to the risk of
D5W 24° x 3 and enhancement apathy addiction, abuse, and
doses of serotonin misuse. Assess each
release may also CV: vasodilation, patient’s risk before
contribute to its hypertension, prescribing.
analgesic effect. peripheral edema
Intervention:
EENT: visual  Monitor CV and
disturbances, respiratory status,
nasopharyngitis, especially within first 24
pharyngitis, rhinitis, to 72 hours of therapy
sinusitis initiation and after
dosage increases; adjust
GI: constipation, doses accordingly.
nausea, vomiting,  Monitor patient
abdominal pain, regularly for
anorexia, diarrhea, development of
dry mouth, abnormal behaviors.
dyspeptia, flatulence  Monitor bowel and
bladder function.
GU: proteinuria, Anticipate need for
urinary frequency, stimulant laxative.
urine retention,  Monitor patient for drug
pelvic pain, UTI dependence similar to
that of codeine and thus
Metabolic: weight has potential for abuse.
loss
Patient/Family Teaching:
Musculoskeletal:  Instruct the patient to
hypertonia, immediately report
arthralgia, neck pain, difficulty breathing or
myalgia other signs or
symptoms of a potential
Respiratory: adverse opioid-related
bronchitis, reaction.
respiratory  Encourage patient to
depression report all medications
taken, including
Skin: diaphoresis, prescription, OTC
pruritus, rash medications, and
supplements.
 Report severe
constipation, difficulty
breathing, excessive
sedation, muscle
weakness, tremors,
chest pain, and
palpitations.